Literature DB >> 6103483

Arylhydrocarbon hydroxylase activity in lymphocytes of patients with psoriasis.

T Ruzicka, W Vizethum, A Jacobs, G Goerz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6103483     DOI： 10.1016/s0140-6736(80)91596-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Blood monocyte aryl hydrocarbon hydroxylase activity in psoriasis.

Authors:  G Mason; M D Rawlins; S Shuster
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

2.  Alterations in leukocyte aryl hydrocarbon hydroxylase activity associated with treatment and age in psoriasis patients and healthy individuals.

Authors:  K H Kraemer; R C Robinson; R E Tarone; M Protic-Sabljic; H V Gelboin
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

3.  Generalised tissue abnormality of aryl hydrocarbon hydroxylase in psoriasis.

Authors:  P H Chapman; P J Kersey; B Keys; S Shuster; M D Rawlins
Journal:  Br Med J       Date:  1980-11-15

4.  Aryl hydrocarbon hydroxylase activity in cultured lymphocytes of psoriatic patients.

Authors:  N T Kärki; J Karvonen; O Pelkonen
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.